Large-scale cancer proteomic analyses for improved prediction of drug response, patient prognosis and clinical outcome

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1138536

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Proteomics is the study of all of the proteins encoded by a genome. In this project, I will use a new database of proteomic and clinical data from up to 70,000 cancer samples, and create an approach to correlate proteomic features with drug response, patient prognosis and clinical outcome. The aim of this research will be to use proteomics to better guide treatment decisions, with the potential to significantly improve the health of people with cancer, both in Australia and globally.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2022

Funding Scheme: Early Career Fellowships

Funding Amount: $318,768.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Bioinformatics

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

bioinformatics | cancer | cancer biology | protein | proteomics

Related Links